SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Parabolic Drugs board will consider financial results

04 Aug 2012 Evaluate
Parabolic Drugs has informed that a meeting of the board of directors of the company will be held on August 14, 2012, to consider and take on record the audited financial results of the company for the financial year ended on March 31, 2012, the unaudited financial results of the company for the quarter ended on June 30, 2012 and to recommend payment of dividend on equity shares of the company.

The above information is a part of company's filings submitted to BSE.

Parabolic Drugs Share Price

1.05 0.00 (0.00%)
25-Jan-2021 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1212.95
Cipla 1225.15
Zydus Lifesciences 931.00
Lupin 2333.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×